Telomir Pharmaceuticals, Inc. Common Stock (TELO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.31
• Market Cap: $44.35M
• EPS: $-0.37
• 52-Week High: $5.40
• 52-Week Low: $1.05

Market Sentiment

Telomir Pharmaceuticals, Inc. Common Stock currently has a Bullish sentiment score of 0.22.

About Telomir Pharmaceuticals, Inc. Common Stock

Telomir Pharmaceuticals, Inc. (Ticker: TELO) is a pre-clinical-stage biopharmaceutical company based in Baltimore, Maryland, dedicated to advancing innovative therapeutic solutions targeting human stem cell disorders. The company is focused on harnessing proprietary technologies to develop novel treatments that have the potential to improve health outcomes in regenerative medicine. With a strong emphasis on research and development, Telomir aims to position itself at the forefront of stem cel...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Telomir Pharmaceuticals, Inc. Common Stock and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does TELO pay dividends?

Telomir Pharmaceuticals, Inc. Common Stock (TELO) does not currently pay a regular dividend.

What is TELO's market cap?

Telomir Pharmaceuticals, Inc. Common Stock (TELO) has a market capitalization of $44.35M with a current stock price of $1.31.